Document is current
Any future updates will be listed below
-
Authors
Feng, Wei
Beer, Joanne C. https://orcid.org/0000-0001-8583-8467
Hao, Qinyu
Ariyapala, Ishara S.
Sahajan, Aparna
Komarov, Andrei
Cha, Katie
Moua, Mason
Qiu, Xiaolei
Xu, Xiaomei
Iyengar, Shweta
Yoshimura, Thu
Nagaraj, Rajini
Wang, Li
Yu, Ming
Engel, Kate
Zhen, Lucas
Xue, Wen
Lee, Chen-jung
Park, Chan Ho
Peng, Cheng
Zhang, Kaiyuan
Grzybowski, Adrian
Hahm, Johnnie
Schmidt, Susanne V.
Odainic, Alexandru https://orcid.org/0000-0002-2806-6904
Spitzer, Jasper https://orcid.org/0000-0001-9696-2092
Buddika, Kasun
Kuo, Dwight https://orcid.org/0000-0002-1391-2637
Fang, Lei
Zhang, Bingqing
Chen, Steve
Latz, Eicke https://orcid.org/0000-0003-1488-5666
Yin, Yiyuan
Luo, Yuling https://orcid.org/0000-0002-2648-7078
Ma, Xiao-Jun https://orcid.org/0009-0002-1287-9553
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (Excellence Cluster EXC 2151 (ID: 390873048), IRTG2168 (ID: 272482170), Excellence Cluster EXC 2151 (ID: 390873048), IRTG2168 (ID: 272482170))
U.S. Department of Health & Human Services | NIH | National Cancer Institute (1R43CA254548-01)
- License Information
-
More Information
Article History
Received: 22 June 2023
Accepted: 23 October 2023
First Online: 9 November 2023
Competing interests
: W.F., J.B., Q.H., I.S.A., A.S., A.K., K.C., M.M., X.Q., X.X., S.I., T.Y., R.N., L.W., M.Y., K.E., L.Z., W.X., C.L., C.H.P., C.P., K.Z., A.G., J.H., K.S., D.K., L.F., B.Z., S.C., Y.Y., Y.L., and X.M. are employees and stockholders of Alamar Biosciences. Y.L., W.F., A.G., Y.Y., and S.C. have submitted a patent application to US Patent and Trademark Office pertaining to the methods and compositions of NULISA technology (provisional application No. 62/943,135). The other authors do not claim competing interest.
